Claudia Salinas
Family · Eagle Pass, TXNPI 1972755056
Payments from drug & device makers
Across 85 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$179
- Johnson & Johnson$116
- Pfizer$113
- Incyte Corporation$111
- Rigel Pharmaceuticals, Inc.$111
- Sanofi$100
- plus $805 from 24 others
What the payments were for
- Food & beverage$1,534100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 10 | $179 |
| Johnson & Johnson | 7 | $116 |
| Pfizer | 6 | $113 |
| Incyte Corporation | 5 | $111 |
| Rigel Pharmaceuticals, Inc. | 6 | $111 |
| Sanofi | 5 | $100 |
| Novo Nordisk | 6 | $81 |
| AbbVie | 4 | $81 |
| Pharmacosmos Therapeutics Inc. | 4 | $74 |
| EMD Serono, Inc. | 3 | $53 |
| Astellas Pharma US Inc | 3 | $53 |
| Novartis | 3 | $52 |
| Merck | 3 | $50 |
| Lilly USA, LLC | 2 | $43 |
| Bristol Myers Squibb | 2 | $41 |
| GSK | 2 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $22 |
| AMAG Pharmaceuticals, Inc. | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Coherus Oncology, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Myovant Sciences Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Eisai Inc. | 1 | $13 |
How this compares
$1,534 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 49 | $87,648 |
| RybelsusSemaglutide | 35 | $64,754 |
| OzempicSemaglutide | 22 | $49,064 |
| Tresiba Flextouch U-200Insulin Degludec | 53 | $47,430 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 25 | $28,369 |
| JanuviaSitagliptin Phosphate | 17 | $26,511 |
| FarxigaDapagliflozin Propanediol | 13 | $18,658 |
| VascepaIcosapent Ethyl | 12 | $8,469 |
| Rosuvastatin Calcium | 192 | $2,215 |
| Omeprazole | 71 | $1,979 |
| Valsartan | 80 | $1,716 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 14 | $1,643 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 101 | $1,368 |
| Levothyroxine Sodium | 133 | $1,122 |
| Losartan Potassium | 116 | $856 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $81 | $113,81857 claims |
| Boehringer IngelheimJardiance | $13 | $87,64849 claims |
| MerckJanumet Xr, Januvia | $50 | $54,87942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 15,456 family providers in Texas.
Other family in Eagle Pass
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.